February 26, 2020 / 7:41 AM / a month ago

BRIEF-Expres2ion Signs Option To License Agreement With Adaptvac Regarding Unique Breast Cancer Vaccine

Feb 26 (Reuters) - ExpreS2ion Biotech Holding AB :

* EXPRES2ION SIGNS OPTION TO LICENSE AGREEMENT WITH ADAPTVAC REGARDING UNIQUE BREAST CANCER VACCINE

* EXPRES2ION BIOTECH HOLDING AB - OPTION PRICE ENTAILS NO UPFRONT FEE AND CAN MAXIMUM AMOUNT TO DKK 1.2M (SEK 1.7M) DURING FULL OPTION TERM.

* EXPRES2ION BIOTECH HOLDING AB - TERMS OF AGREEMENT WILL CONTAIN FINANCIAL CONSIDERATION TO ADAPTVAC IN FORM OF UPFRONT PAYMENT AT SIGNATURE OF DKK 2.5M Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below